Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2015/12/006407
CTRI/2015/12/006407
Recruiting
Phase 1

HYPO-FRACTIONATED RADIOTHERAPY SCHEDULE OF 35GY IN 10FRACTIONS IN ADVANCED INCURABLE BREAST CANCER: A PROSPECTIVEPHASE I/II STUDY - HYPORT

Tata Medical Center0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Breast Cancer

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: null- Breast Cancer
Sponsor
Tata Medical Center
Enrollment
30
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.ECOG\-0,1,2
  • •2\.Locally advanced breast cancer which is not amenable to curative surgery as decided by multidisciplinary tumor board.
  • •3\.Metastatic breast cancer patients:awaiting palliative locoregional radiotherapy for symptom(pain bleeding, ulceration, impending fungation)control.
  • •4\.who have completed a scheduled course of palliative chemotherapy and is felt to benefit from local radiation therapy.

Exclusion Criteria

  • •1\.Breast reconstruction using implants
  • •2\.Concurrent cytotoxic chemotherapy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Short course palliative radiotherapy for symptom relief in large inoperable cancer of breastHealth Condition 1: null- Advanced Incurable Breast Cancer in Female
CTRI/2018/04/013209Tata Medical Center31
Not yet recruiting
Phase 2
Higher cumulative dose, 6days/week vs standard, 5days/week moderately hypofractionated palliative radiotherapy with concurrent chemotherapy in locally advanced head and neck carcinoma.
CTRI/2023/10/058621AIIMS, New Delhi
Completed
Not Applicable
Palliative Hypofractionated Radiotherapy in Advanced Incurable Breast CancerCarcinoma Breast Stage IV
NCT03511781Tata Medical Center30
Recruiting
Phase 3
Standard moderately hypofractionated radiotherapy vs. ultra-hypofractionated focal lesion ablative microboost in prostate cancer, Hypo-FLAME 3.0prostate cancer10038597
NL-OMON56327Antoni van Leeuwenhoek Ziekenhuis352
Unknown
Phase 2
Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial)Myxoid Liposarcoma
NCT03816475Maria Sklodowska-Curie National Research Institute of Oncology35